ClinicalTrials.govpublic full text
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
malignant neoplasms stated as primary lymphoid haematopoietic, multiple myeloma, newly diagnosed, nivolumab, bms-936558, opdivo, lenalidomide, cc-5013, revlimid, dexamethasone, decadron, ipilimumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 861392
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.